Aeroquin: Phase III data
The open-label, international Phase III 209 trial in 282 CF patients with P. aeruginosa infection showed that twice-daily 240 mg Aeroquin for the first 28
Gathering data...
The open-label, international Phase III 209 trial in 282 CF patients with P. aeruginosa infection showed that twice-daily 240 mg Aeroquin for the first 28